By: Akosua Mireku
In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in oncology.
Akosua Mireku is a healthcare reporter for Pharmaceutical-Technology. With a focus on the pharmaceutical industry, Akosua covers a wide range of topics including regulatory issues, clinical trials, drug manufacturing, and the impact of healthcare policies on the industry. Her reporting provides insights into the latest developments and challenges in the field of pharmaceuticals.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Akosua Mireku's articles primarily focus on the healthcare and pharmaceutical industry, with an emphasis on regulatory developments, company announcements, and data-driven insights. She is likely to be interested in hearing from experts who can provide analysis or commentary on legislative changes impacting the pharmaceutical sector.
Given her coverage attributes that highlight reliance on press releases, government announcements, and cited data sources, she may value pitches featuring exclusive access to relevant industry data or interviews with key figures involved in major healthcare and pharmaceutical developments.
It's important for potential sources to provide well-researched insights into topics such as biotech development, FDA regulations, drug manufacturing processes or challenges within the pharmaceutical industry.
This information evolves through artificial intelligence and human feedback. Improve this profile .